P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B-CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB
- DOI
- 10.1097/01.hs9.0000969436.70152.b3
- Published
- 2023-08
- Container
- HemaSphere
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/01.hs9.0000969436.70152.b3,
title = {P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B-CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB},
author = {Mazyar Shadman and Moshe Y. Levy and Ryan Porter and John M. Burke and Jennifer L. Cultrera and Jamal Misleh and Jeff Sharman and Syed F. Zafar and Kunthel By and Aileen Cohen and Rocco Crescenzo and Adam Idoine and Ian W. Flinn},
year = {2023},
journal = {HemaSphere},
doi = {10.1097/01.hs9.0000969436.70152.b3},
url = {https://doi.org/10.1097/01.hs9.0000969436.70152.b3}
}RIS
TY - JOUR TI - P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B-CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB AU - Mazyar Shadman AU - Moshe Y. Levy AU - Ryan Porter AU - John M. Burke AU - Jennifer L. Cultrera AU - Jamal Misleh AU - Jeff Sharman AU - Syed F. Zafar AU - Kunthel By AU - Aileen Cohen AU - Rocco Crescenzo AU - Adam Idoine AU - Ian W. Flinn PY - 2023 JO - HemaSphere DO - 10.1097/01.hs9.0000969436.70152.b3 UR - https://doi.org/10.1097/01.hs9.0000969436.70152.b3 ER -
APA
Shadman, M., Levy, M. Y., Porter, R., Burke, J. M., Cultrera, J. L., Misleh, J., Sharman, J., Zafar, S. F., By, K., Cohen, A., Crescenzo, R., Idoine, A., & Flinn, I. W. (2023). P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B-CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB. HemaSphere. https://doi.org/10.1097/01.hs9.0000969436.70152.b3
Source records
- crossref · retrieved 2026-09-26T22:13:46.963Z